Видео с ютуба Lenalidomide

Why Is Cancer Drug Revlimid So Expensive?

Lenalidomid (Revlimid) – lek immunomodulujący (IMiD) w leczeniu szpiczaka mnogiego

Lenalidomide's place in the myeloma treatment landscape

The impact of lenalidomide on second primary malignancies: long-term data from the Myeloma XI Trial

What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?

Lenalidomide for smoldering myeloma

Toxicities Associated With Lenalidomide for Multiple Myeloma

Dr. Leonard on Lenalidomide With Rituximab in Follicular Lymphoma

Lenalidomide in hematologic malignancies - Video abstract [ID 81310]

Lenalidomide as a Highly-Effective Maintenance Therapy in Myeloma

Novel Anti-Cancer Agents for Multiple Myeloma

Graham Jackson, MD: Lenalidomide Maintenance Is Effective in All Types of Myeloma Patients

Effects of Dose Reductions of Lenalidomide in Myeloma Patients | Jens Hillengass, MD, PhD | ASH 2023

Myeloma Doctor Talks About Lenalidomide

Dr. Schuster on Long-Term Outcomes of Lenalidomide and Rituximab in MCL

OPTIMISMM: investigating an alternative therapy for lenalidomide-refractory patients

Benefit of treating smouldering myeloma patients early with lenalidomide & dexamethasone

Results of RELEVANCE: frontline rituximab-lenalidomide for follicular lymphoma

Lenalidomide maintenance remains best for newly diagnosed MM

Should I interrupt or discontinue therapy in patients with lenalidomide-induced rash?